Schettini G, Quattrone A, Di Renzo G, Lombardi G, Preziosi P
Eur J Pharmacol. 1979 Jun;56(1-2):153-7. doi: 10.1016/0014-2999(79)90445-x.
6-Hydroxydopamine (6-OHDA) (two doses of 200 micrograms each, administered intraventricularly at a 48 h interval) caused a marked decrease of hypothalamic noradrenaline content and blocked the TSH rise elicited by cold exposure. Clonidine (0.4 mg/kg i.p.), a noradrenaline receptor agonist, was able to reverse the 6-OHDA of cold-induced TSH surge. The plasma TSH levels after cold stress in rats treated with 6-OHDA + clonidine were significantly higher than in vehicle + clonidine-injected animals, thus suggesting the presence of noradrenaline receptor supersensitivity in 6-OHDA-pretreated rats. 6-OHDA did not modify the basal concentrations of TSH but the administration of clonidine to 6-OHDA-injected animals caused a significant increase in thyrotropin secretion when compared with the vehicle + clonidine group.
6-羟基多巴胺(6-OHDA)(每次200微克,分两次给药,间隔48小时经脑室注射)导致下丘脑去甲肾上腺素含量显著降低,并阻断了冷暴露引起的促甲状腺激素(TSH)升高。可乐定(0.4毫克/千克,腹腔注射),一种去甲肾上腺素受体激动剂,能够逆转6-OHDA对冷诱导的TSH激增的影响。6-OHDA +可乐定处理的大鼠在冷应激后的血浆TSH水平显著高于注射溶媒+可乐定的动物,这表明6-OHDA预处理的大鼠存在去甲肾上腺素受体超敏反应。6-OHDA并未改变TSH的基础浓度,但与溶媒+可乐定组相比,给注射6-OHDA的动物注射可乐定导致促甲状腺素分泌显著增加。